News | Graduate School of Medical Sciences

students at graduation reciting the Hippocratic oath.

Commencement Returns to Carnegie Hall, Marking Joyous Day For Graduates

Video of Congratulations to the Class of 2022 | Weill Cornell Medicine

Dr. Meridith Pollie was always interested in math and science, but a volunteer opportunity working and bonding with patients at a long-term health care facility inspired her to dedicate those passions in service of others.

“I realized that I got a whole different kind of fulfillment from building relationships with people whom I can potentially help,” said Dr. Pollie, who through those patient...

Dr. John MacMicking Wins Graduate School of Medical Sciences Alumni Award of Distinction

Dr. John MacMicking, a Howard Hughes Medical Institute Investigator and professor of immunobiology and microbial pathogenesis at Yale University School of Medicine, has been awarded the 2022 Graduate School of Medical Sciences Alumni Award of Distinction.

Since 1997, graduate school alumni have been recognized with this award for their outstanding contributions to biomedical research in education, focusing on science and scholarship, leadership, mentoring and teaching, and service to...

Graduate Students Recognized at Convocation

The Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2022 for their academic achievements during its convocation ceremony on May 18.

The ceremony recognized students who are graduating with their master’s degrees, as well as those who earned special awards and prizes for their accomplishments accomplishments in research, scholarship and service.

In addition to honoring students, the ceremony also recognized the 2022 Weill Cornell Graduate School...

Advance in Understanding Cell Division Could Lead to New Cancer Treatments

A protein called CDC7, long thought to play an essential role early in the cell division process, is in fact replaceable by another protein called CDK1, according to a study by investigators at Weill Cornell Medicine and the Dana-Farber Cancer Institute. The finding represents a fundamental advance in cell biology and may lead to new cancer therapies, since cancers frequently alter the molecular machinery of cell division to sustain their rapid growth.

The study, published online May 4...

Study Reveals Structure of Anti-Tumor Therapy’s Target

Using cutting-edge techniques, Weill Cornell Medicine and Memorial Sloan Kettering investigators have visualized the structure of a receptor targeted by an anti-cancer immunotherapy. The new information may help scientists improve this type of cancer treatment.

The study, published Feb. 25 in Science Advances, used cryo-electron microscopy (cryo-EM) to reveal the full-length structure of the glucocorticoid-induced tumor necrosis factor receptor (GITR), an advance over previous studies...

New Collaborations Win Funding from Starr Cancer Consortium

Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.

The Starr Cancer Consortium, established in 2006, is a collaboration among five leading research institutions: The Broad Institute of MIT...

New Discovery May Help Reduce Side Effects of Multiple Sclerosis Drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

The study, published Feb. 8 in Nature Communications, details the precise molecular structure of the multiple sclerosis drug siponimod as it interacts with its target, the human S1P receptor 1 (S1P1), and off-target receptors using a cutting-edge electron microscopy...

Two Weill Cornell Medicine Faculty Members Inducted into ASCI

Two Weill Cornell Medicine physician-scientists, Dr. Randy Longman and Dr. Robert Schwartz, have been elected as members of the American Society for Clinical Investigation.

The American Society for Clinical Investigation (ASCI) is one of the nation’s oldest nonprofit medical honor societies and focuses on the unique role of physician-scientists in research, clinical care and medical education. It is comprised of more than 3,000 physician-scientists serving in the upper ranks of...

A New and Versatile Genetic Manipulation Pipeline for Studying Nonmodel Gut Bacteria

Scientists at the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine have developed a pipeline that enables genetic manipulation of nonmodel gut bacteria. The pipeline will allow scientists to study the biological roles of these bacteria, which are increasingly recognized as key factors in health and disease, at the single-gene level.

Scientists have developed advanced genetic tools for some model gut bacteria, such as E. coli, but have lacked...

Researchers Identify Key Regulator of Blood Stem Cell Development

A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study from researchers at Weill Cornell Medicine.

The protein, known as histone H3.3, organizes the spool-like structures around which DNA is wrapped in plants, animals and most other organisms. Histones enable DNA to be tightly compacted, and serve as platforms for small chemical...

1 of 21
next ›